Filing Details

Accession Number:
0001209191-20-036386
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-12 18:00:12
Reporting Period:
2020-06-10
Accepted Time:
2020-06-12 18:00:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Therapeutics Public Ltd Co HZNP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1769107 Jeff Kent C/O Horizon Therapeutics Plc
Connaught House, 1St Fl, 1 Burlington Rd
Dublin L2 4
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2020-06-10 5,000 $0.00 65,994 No 4 M Direct
Ordinary Shares Disposition 2020-06-10 2,216 $48.60 63,778 No 4 F Direct
Ordinary Shares Disposition 2020-06-10 2,785 $48.05 60,993 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Restricted Stock Units (RSU) Disposition 2020-06-10 5,000 $0.00 5,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 No 4 M Direct
Footnotes
  1. Each RSU represents a contingent right to receive one ordinary share of the Issuer.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2020.
  3. On June 10, 2018, the reporting person was granted 15,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.